Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

Januzzi, James L; Zannad, Faiez; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Pocock, Stuart J; Ferreira, João Pedro; Sattar, Naveed; Verma, Subodh; Vedin, Ola; +4 more... Schnee, Janet; Iwata, Tomoko; Cotton, Dan; Packer, Milton; EMPEROR-Reduced Trial Committees and Investigators; (2021) Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial. Journal of the American College of Cardiology, 78 (13). pp. 1321-1332. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2021.07.046

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2021.07.046

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 34556318
Elements ID 166380

Share

Download

Filename: 1-s2.0-S0735109721057843-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar